Evidence receipt / evaluation
Published · transcript-backedDavid Rosenthal: evaluation
22 Jan 2024 Acquired Novo Nordisk (Ozempic)
“Years later, actually, the Nobel Committee would basically admit that they messed that up. It turns out that the answer to that is the key to the first chapter of our story today, because the actual nomination, I don't know if you knew this, Ben, for that prize was put forth by a previous Nobel Prize winner in physiology or medicine, the 1920 Nobel Prize winner from the Copenhagen, Denmark, an animal biologist named August Krogh, who also happens to be the founder of Novo Nordisk.”
Source trail
Everything needed to verify it.
- Speaker
- David Rosenthal
- Attribution
- Verified speaker
- Claim type
- evaluation
- Recorded
- 22 Jan 2024
- Publisher
- Acquired
- Episode
- Novo Nordisk (Ozempic)
Transcript context
…Much more diverse, but not too much larger by market cap. Back to this whole Nobel Prize thing, which as we said, was awarded to Banting and Assistant Medical School Dean John Mcleod. Now, how did Macleod end up being the guy who shares the award with Banting and not Best? Years later, actually, the Nobel Committee would basically admit that they messed that up. It turns out that the answer to that is the key to the first chapter of our story today, because the actual nomination, I don't know if you knew this, Ben, for that prize was put forth by a previous Nobel Prize winner in physiology or medicine, the 1920 Nobel Prize winner from the Copenhagen, Denmark, an animal biologist named August Krogh, who also happens to be the founder of Novo Nordisk. Is that how Nobel Prizes work? A previous winner nominates the current nominees? Or it certainly helps their case if a previous winner?…
Stored transcript either side of the excerpt. The highlighted words are the published quote; the surrounding text is unedited source, never generated.